The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.
The Scientist
Most Recent
A new policy will require federal agencies to perform a careful review of research involving 15 pathogens and toxins that could be used for bioterrorism, including H5N1.
Early exposure to microbes shapes the mammalian immune system by subduing inflammatory T cells.
Replacing immune cells in a mouse model of Rett syndrome, a developmental brain disorder, improved symptoms, suggesting a new target for treatment.
A series of articles published in open access journal mBio underscores the variety in opinion on whether a transmissible H5N1 strain should be studied.
A new method for transplanting immunologically mismatched organs may remove the need for life-long immunosuppressive drugs to prevent rejection.
NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.
Biosecurity agency will give controversial H5N1 bird flu research another look-over in light of new data and clarification.
A lot changes in a child’s body over the course of development, and not all changes occur linearly: gene expression can fluctuate, and organs can perform different functions on the way to their final purpose in the body. Here are some of the key deve
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
